Orchestra BioMed Hldgs Q3 EPS $(0.40) Beats $(0.42) Estimate, Sales $861.000K Beat $757.600K Estimate
Benzinga Newsdesk 11 months ago
EarningsEarnings BeatsNews
Orchestra BioMed Hldgs (NASDAQ:OBIO) reported quarterly losses of $(0.40) per share which beat the analyst consensus estimate of $(0.42) by 5.21 percent. This is a 2.44 percent increase over losses of $(0.41) per share
Orchestra BioMed Hldgs (NASDAQ:OBIO) reported quarterly losses of $(0.40) per share which beat the analyst consensus estimate of $(0.42) by 5.21 percent. This is a 2.44 percent increase over losses of $(0.41) per share from the same period last year. The company reported quarterly sales of $861.000 thousand which beat the analyst consensus estimate of $757.600 thousand by 13.65 percent. This is a 12.77 percent decrease over sales of $987.000 thousand the same period last year.